Prevalence of hepatitis B virus ( HBV ) and latent tuberculosis co‐infection and risk of drug‐induced liver injury across two large HBV cohorts in the United States
Journal of Viral Hepatitis · 2023
DOI: 10.1111/jvh.13823 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2023. Verfasst von Robert J Wong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Latent Tuberculosis, Coinfection, Hepatitis B, Hepatitis B, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: American College of Gastroenterology.
Abstract (Originalsprache)
The epidemiology of latent tuberculosis and hepatitis B virus (HBV‐LTBI) co‐infection among U.S. populations is not well studied. We aim to evaluate LTBI testing patterns and LTBI prevalence among two large U.S. cohorts of adults with chronic HBV (CHB). Adults with CHB in the Chronic Hepatitis Cohort Study (CHeCS) and Veterans Affairs national cohort were included in the analyses. Prevalence of HBV‐LTBI co‐infection was defined as the number of HBV patients with LTBI divided by the number of HBV patients in a cohort. Multivariable logistic regression evaluated odds of HBV‐LTBI co‐infection among CHB patients who underwent TB testing. Among 6019 CHB patients in the CHeCS cohort (44% female, 47% Asian), 9.1% were tested for TB, among whom 7.7% had HBV‐LTBI co‐infection. Among HBV‐LTBI co‐infected patient, only 16.7% ( n = 7) received LTBI treatment, among whom 28.6% ( n = 2) developed DILI. Among 12,928 CHB patients in the VA cohort (94% male, 42% African American, 39% non‐Hispanic white), 14.7% were tested for TB, among whom 14.5% had HBV‐LTBI. Among HBV‐LTBI co‐infected patient, 18.6% ( n = 51) received LTBI treatment, among whom 3.9% ( n = 3) developed DILI. Presence of cirrhosis, race/ethnicity, and country of birth were observed to be associated with odds of HBV‐LTBI co‐infection among CHB patients who received TB testing. In summary, among two large distinct U.S. cohorts of adults with CHB, testing for LTBI was infrequent despite relatively high prevalence of HBV‐LTBI co‐infection. Moreover, low rates of LTBI treatment were observed among those with HBV‐LTBI co‐infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA.
- Gastroenterology Section, Veterans Affairs Palo Alto Healthcare System, Palo Alto, California, USA.
- Center for Health Policy & Health Services Research, Henry Ford Health System, Detroit, Michigan, USA.
- Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA.
- Center for Integrated Health Care Research, Kaiser Permanente Hawaii, Portland, Oregon, USA.
- Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.
ORCID-Profile: Robert J Wong, Mei Lu
Förderung
- American College of Gastroenterology
Zitieren
APA
Wong, R. J., Rupp, L., Lu, M., Yang, Z., Daida, Y. G., Schmidt, M., Boscarino, J. A., Gordon, S. C., & Chitnis, A. S. (2023). Prevalence of hepatitis B virus ( HBV ) and latent tuberculosis co‐infection and risk of drug‐induced liver injury across two large HBV cohorts in the United States. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.13823
Vancouver
Wong RJ, Rupp L, Lu M, Yang Z, Daida YG, Schmidt M, et al. Prevalence of hepatitis B virus ( HBV ) and latent tuberculosis co‐infection and risk of drug‐induced liver injury across two large HBV cohorts in the United States. Journal of Viral Hepatitis. 2023. doi:10.1111/jvh.13823
BibTeX
@article{Wong2023,
author = {Wong, Robert J and Rupp, Loralee and Lu, Mei and Yang, Zeyuan and Daida, Yihe G and Schmidt, Mark and Boscarino, Joseph A and Gordon, Stuart C and Chitnis, Amit S},
title = {Prevalence of hepatitis B virus ( HBV ) and latent tuberculosis co‐infection and risk of drug‐induced liver injury across two large HBV cohorts in the United States},
journal = {Journal of Viral Hepatitis},
year = {2023},
doi = {10.1111/jvh.13823}
}
EUVIMED